Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.

Abstract

Mesothelioma, a highly aggressive cancer with poor prognosis and refractory to currently available therapies show increasing trends of its incidence in Japan and other developing countries. Although surgery is a gold standard for patients with early mesothelioma, most patients with advanced disease are not suitable… (More)
DOI: 10.3892/or.2011.1449

Topics

Cite this paper

@article{Amatya2011OverexpressionOC, title={Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.}, author={Vishwa Jeet Amatya and Yukio Takeshima and Kei Kushitani and Taketo Yamada and Chikao Morimoto and Kouki Inai}, journal={Oncology reports}, year={2011}, volume={26 6}, pages={1369-75} }